H.C. Wainwright Reiterates Buy Rating on Corcept Therapeutics (CORT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 118.54 -1.06 (0.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $119.60 | 52 Week High | $10.00 | |||
| Open | $118.56 | 52 Week Low | $3.22 | |||
| Day High | $119.16 | P/E | N/A | |||
| Day Low | $115.80 | EPS | $-0.46 | |||
| Volume | 494,260 | |||||
